BioSpace

Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck

Regeneron executives struck an upbeat tone on an investor call Friday as the biotech posted a consensus-beating $5.1 billion in third quarter earnings and CEO Leonard Schleifer touted the company’s ‘disease agnostic’ pipeline and approach to business development.

By BioSpace

1 min read
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights